The best way to study exposures and biological age is to treat biological age as a signal that changes over time, not a one-off score. Measure a realistic set of exposures repeatedly, choose a biological age measure that fits the question, control for confounding and batch effects from the start, and focus on modifiable exposures such as smoking, sleep, air quality, diet and stress.

In short: - Repeated measures in the same people tell you far more than a single snapshot. - Measure exposures as clusters, not one at a time: smoking, sleep, air pollution, diet, stress and socioeconomic context often travel together. - Pick one primary biological age measure that matches your question. Different clocks capture different aspects of ageing. - Pre-specify hypotheses, adjust for confounding, and claim causation only when the design supports it.

Why do exposures matter in biological age research?

Exposures are often the main signal in biological age research, not background noise. In an exposome-wide analysis of almost half a million UK Biobank participants, environmental and lifestyle exposures explained an additional 17 percentage points of variation in mortality, while polygenic risk scores for 22 major diseases added less than 2 (Argentieri et al., 2025).

Biological age measures are useful here because they aim to capture the state of the body rather than the number of birthdays. Chronological age cannot tell a researcher whether someone's biology has been shaped by years of poor sleep, tobacco exposure or cleaner living. A biological age measure may capture part of that cumulative burden.

Capturing an association is not the same as proving a cause, though. Some exposures travel with many others. Poor sleep often coexists with shift work, stress, low physical activity or cardiometabolic problems. Smoking often coexists with socioeconomic disadvantage, alcohol use and other environmental burdens.

So instead of asking "Does one exposure affect biological age?", ask: "How does a set of real-world exposures shape biological age over time, once the obvious sources of bias are accounted for?"

Which exposures should a study prioritize?

Prioritize exposures that are common, measurable, biologically plausible and potentially actionable. For an overview of the drivers wellness teams most often track, see our article on factors that drive ageing.

Smoking, including early-life tobacco exposure, remains a top priority. Among 276,259 UK Biobank participants, those exposed to tobacco in utero had higher biological age acceleration as adults, and starting to smoke earlier was associated with faster biological ageing in a dose-response pattern (Cui et al., 2024). Participant history therefore matters: a healthy-looking snapshot today may still carry older exposure burdens.

Sleep is common, modifiable and interacts with other exposures. In UK Biobank, poorer sleep quality was associated with accelerated biological ageing, and good sleep weakened the association between air pollution and biological age acceleration (Gao et al., 2022).

Air pollution, particularly fine particulate matter, is increasingly linked to accelerated biological ageing and to ageing-related disease. The evidence is most consistent for composite clinical measures such as PhenoAge, while findings for DNA methylation clocks remain inconclusive across studies (Poursafa & Jylhävä, 2026).

Diet, physical activity, stress and socioeconomic context are core exposures too, not "soft" variables. Smoking, diet, socioeconomic factors and pollutants are among the exposures examined in studies that test epigenetic age as a link between exposure and disease (Fujii et al., 2026). In wellness settings, they are often the easiest exposures to track and to change.

To rank candidate exposures, ask three questions:

  1. Can you measure it with reasonable accuracy?
  2. Can a participant or clinic act on it?
  3. Is there a plausible pathway linking it to ageing biology?

If the answer to all three is no, the variable may be academically interesting, but it is not a first-line target for wellness research.

Why should exposure studies be longitudinal?

Because repeated measures show change; single measurements only show differences between people. Measuring the same participants over time lets you see trajectories, persistence and response to a change in exposure. For a closer look at what repeat testing adds in practice, see how repeat biological age testing reduces guesswork.

A good wellness design usually includes a baseline biological age measure, a baseline exposure profile and at least one follow-up after a meaningful interval. The right interval depends on the exposure: quitting smoking, better sleep, major weight change, recovery from infection or moving to a cleaner area may each work on a different timescale. Don't assume every intervention should move biological age quickly.

Repeated measures also guard against over-reading noisy single scores. Technical noise alone can make six widely used epigenetic clocks differ by up to 9 years between replicates of the same sample (Higgins-Chen et al., 2022). Sample quality, shifts in blood cell composition and normal day-to-day variation add to that. With several time points, you can tell plausible biological change from measurement noise.

Plan for confounding from the start

At minimum, most studies should account for age, sex, smoking, BMI or another adiposity measure, relevant medication, socioeconomic factors and, with blood-based DNA methylation, cell-type composition, which can be estimated from the methylation data itself (Houseman et al., 2012). Timing matters too: season, acute illness, poor sleep before sampling and recent major stress can all distort a result.

The useful mindset is not "collect more variables because more is better", but "collect the variables that will let you interpret the result". A smaller, cleaner longitudinal dataset often beats a large cross-sectional one with weak exposure measurement.

Which biological age measure fits your question?

There is no universally best biological age measure, only the best one for your question. In exposure research, some measures are built around mortality risk, others around the pace of ageing, specific organs or overall physiology.

A scoping review of 22 studies that tested epigenetic age as a mediator between exposures and health outcomes found that most used blood-based DNA methylation, with GrimAge, PhenoAge and DunedinPACE used most often (Fujii et al., 2026). These measures are widely studied, but they are not interchangeable:

  • Risk-oriented clocks such as GrimAge and PhenoAge were developed to predict mortality and age-related disease (Lu et al., 2019; Levine et al., 2018). They suit questions about broad exposure burden and downstream risk.
  • Pace-oriented measures such as DunedinPACE estimate how fast someone is ageing and were designed to detect change in response to interventions (Belsky et al., 2022). They suit questions about change after a lifestyle program.
  • Organ-specific measures matter when an exposure may affect one organ system more than others; a single systemic age can miss that.

In exposure research it also helps to know why a measure gives the result it does. PredictMe's explainable biological age model, for example, traces each prediction back to the CpG sites and biological processes that drive it. That makes it easier to see which processes an exposure appears to affect, not just whether biological age differs. Read more about PredictMe's models for researchers.

Measures can also disagree. In the CALERIE randomized trial, two years of caloric restriction slowed the pace of ageing measured by DunedinPACE, but did not significantly change PhenoAge or GrimAge, and the effects were small (Waziry et al., 2023). That does not invalidate the result; it may mean the exposure moved one dimension of ageing biology more than another. Decide in advance how you will interpret disagreement, instead of building a story after the data arrive.

Generational research points the same way. In UK Biobank, systemic biological age measured by PhenoAge was higher in more recent birth cohorts, and both systemic and organ-specific ageing measures were associated with early-onset cancer risk (Tian et al., 2026). Where feasible, combine a systemic measure with organ-relevant analysis.

Three practical rules:

  • Use one primary biological age endpoint, not a shopping list of clocks in the hope that one becomes significant.
  • Add secondary measures only if they answer a distinct question.
  • Pre-specify how you will interpret disagreement between measures.

For more on choosing between measures, see how to choose DNA methylation biomarkers for biological age studies.

A practical study framework by use case

Use this framework before you launch a consumer pilot, a clinic service evaluation or an academic study.

Use case Best-fit design Primary measure Exposure collection Timing Minimum practical QC
Consumer wellness tracking Single-arm longitudinal within-person study One validated measure with known repeat-test reliability; a secondary measure only if predefined Standardized questionnaire plus app or wearable logs for sleep, activity, smoking, alcohol and diet; geocoded pollution if available Baseline plus 6–12 month follow-up; avoid very short retesting Fixed sampling instructions, same sample type, same processing pipeline, blind duplicates, prespecified retest rules
Private clinic program evaluation Prospective cohort, ideally with a matched comparison group One risk-oriented or systemic clock for broad risk communication; one pace measure for tracking change Intake history, medication list, anthropometrics, validated sleep and stress tools, optional device data, log of exposure changes Baseline, a mid-point if the intervention is intensive, then 6–12 months Batch-balanced runs, cell-composition adjustment, samples randomized across plates, predefined exclusion criteria
Academic exposure study Longitudinal cohort or nested intervention; cross-sectional only for discovery Matched to the hypothesis: risk-oriented for downstream events, pace-oriented for short-term change, organ-specific secondary if justified Validated exposure instruments, repeated measures, registry or geospatial linkage where possible, biomarker validation for key exposures such as smoking At least two time points, ideally three for trajectory modeling; interval matched to the exposure's biology Technical replicates, control samples, batch-correction plan, preregistered analysis, missing-data strategy

Spreading samples across plates and runs matters because batch effects lead to wrong conclusions when they line up with the groups you compare (Leek et al., 2010).

On sample size: small exploratory consumer or clinic studies are useful for feasibility, adherence and variance estimates, but not for strong claims. For hypothesis-testing academic work, base the sample size on the expected within-person change, measurement variance and attrition, not on a generic target.

How to analyze exposures and biological age without overclaiming

The biggest mistake in wellness biological age research is overclaiming. A study finds that people with worse sleep or more pollution have older biological profiles, and the language quickly shifts to "this exposure ages you by X years". That is usually too strong. Our article on common methylation pitfalls in wellness research covers more of these traps.

Pre-specify the analysis. Define the exposure, the biological age endpoint, the follow-up interval, the covariates and the expected direction of effect before you look at the data. If you are exploring rather than testing, say so.

Model exposures realistically. People are exposed to mixtures, not single variables. Exposome-wide work identifies many independent exposures linked to ageing and mortality (Argentieri et al., 2025), so multipollutant models, cumulative lifestyle scores or clustering can be more informative than one-variable-at-a-time analyses.

Use mediation analysis carefully. A growing number of studies test whether epigenetic age mediates the link between an exposure and a health outcome, but many lack methodological rigor (Fujii et al., 2026). In observational data, unmeasured confounding can distort both the exposure-to-biomarker and biomarker-to-outcome paths, so present mediation results as suggestive unless the design is especially strong.

Report effect sizes in human terms. "A 0.2 standard deviation increase in age acceleration" is statistically correct but hard for readers or clinicians to use. Where appropriate, translate it into relative differences, trajectory changes or rank shifts, and say what remains uncertain.

Distinguish three kinds of claim:

  • Association: the exposure and biological age move together.
  • Tracking: biological age changes alongside a change in exposure over time.
  • Causation: changing the exposure caused the change in biological age.

Most wellness studies can support the first, some the second, and few can establish the third.

What does good wellness research look like in practice?

A strong wellness study of exposures and biological age often looks unremarkable, which is a good sign. It recruits a clearly defined population, measures a realistic set of exposures well, uses a validated biological age endpoint, repeats measurement over time and avoids dramatic claims.

For example, a study might follow adults for 6 to 18 months with repeated blood-based DNA methylation sampling, logs of sleep, smoking, physical activity and diet, geocoded air-quality estimates and basic clinical information. The main question is set in advance: do changes in a composite exposure-burden score track changes in a primary biological age measure after adjustment for confounding?

This is where wellness platforms and research teams can add value: not by promising diagnosis, but by turning complex exposure and methylation data into interpretable signals over time. Done well, that supports prevention, participant engagement and hypotheses for more rigorous studies.

For consumers, the most credible biological age result is not the most dramatic number. It is the one that is repeated over time and linked to exposures you can understand and change.

Frequently asked questions

Which exposures should a biological age study measure first?

Start with exposures that are common, measurable, plausibly linked to ageing biology and possible to change: smoking history (including early-life exposure), sleep, air pollution, diet, physical activity, stress and socioeconomic context. Measure them together rather than one at a time, because they tend to cluster and interact.

How often should biological age be retested in an exposure study?

At least twice: a baseline and a follow-up after an interval that suits the exposure. For consumer or clinic tracking, a follow-up after 6 to 12 months is a practical default. Three or more time points make it easier to separate real change from measurement noise and to model trajectories.

Can a study show that an exposure speeds up biological ageing?

Most observational wellness studies can show an association, and repeated measures can show that biological age tracks changes in exposure. Showing causation usually requires a randomized or otherwise very strong design. Report which of these claims your data support, and avoid phrases like "this ages you by X years".

Which biological age measure is best for exposure research?

None is best in general. Risk-oriented clocks such as GrimAge and PhenoAge suit questions about long-term risk; pace-oriented measures such as DunedinPACE suit questions about change after an intervention. Choose one primary measure that matches your question and decide in advance how to interpret disagreement between measures.

Plan your exposure study

Before collecting the first sample, settle four things: one primary question, one primary biological age endpoint, one repeatable way to collect exposure data, and one quality-control plan. That is where biological age becomes useful rather than just interesting.

Designing a study of exposures and ageing? PredictMe works with research teams on epigenetic research and biological age analysis. Read more about researching with PredictMe.